Satsuma Pharma Agrees To Be Acquired By Shin Nippon Biomedical
17/4 05:30
(RTTNews) - Satsuma Pharmaceuticals Inc. (STSA) agreed to be acquired by Shin Nippon Biomedical Laboratories Ltd. for $0.91 in cash per share at the closing of the transaction plus one non-tradeable contingent value right of up to $5.77 per share....